AdvisorShares Psychedelics ETF PSIL
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 1.00%
- Net assets
- $44.4M
- Holdings
- 32
- 12-month distribution yield
- 7.92%
- Asset class
- Equity
AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund listed on NYSE Arca in the United States, issued by AdvisorShares. Its category is Equity · Global (equity). Its last price was US$21.27 on 20 Oct 2026. Its net expense ratio is 1% a year, from its prospectus dated 1 Nov 2025. It reported net assets of US$44.43 million as of 30 Jun 2026. Its latest holdings report lists 32 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$1.68 a unit, a 12-month distribution yield of 7.92%, paid quarterly.
Fees
- Total annual operating expenses (gross)
- 1.84%
- Net, after fee waivers or reimbursements
- 1.00%
- Management fee
- 0.60%
- Prospectus date
- 1 Nov 2025
- Filed with the SEC
- 28 Oct 2025
Size and reporting
- Net assets
- $44,429,797
- Total assets
- $45,904,368
- Holdings as of
- 30 Jun 2026
- Report made public
- 21 Aug 2026 (52 days after the month end)
Top holdings
Largest 25 of 32 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | DEFINIUM THERAPEUTICS INC DEFINIUM THERAPEUTICS INC COM SHS | CA24477V1058 | 12.85% | $5.7M | Equity (common) | Canada | USD |
| 2 | COMPASS PATHWAYS PLC COMPASS PATHWAYS PLC SPONSORED ADS | US20451W1018 | 11.45% | $5.1M | Equity (common) | United Kingdom | USD |
| 3 | ATAIBECKLEY INC ATAIBECKLEY INC COM SHS | US04650F1012 | 10.47% | $4.7M | Equity (common) | United States | USD |
| 4 | RELMADA THERAPEUTICS INC RELMADA THERAPEUTICS INC COM | US75955J4022 | 6.84% | $3.0M | Equity (common) | United States | USD |
| 5 | NRX PHARMACEUTICALS INC NRX PHARMACEUTICALS INC COM NEW | US6294442099 | 6.07% | $2.7M | Equity (common) | United States | USD |
| 6 | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM | US64125C1099 | 4.38% | $1.9M | Equity (common) | United States | USD |
| 7 | CYBIN INC CYBIN INC COM NEW | CA23256X4075 | 4.35% | $1.9M | Equity (common) | Canada | USD |
| 8 | GH RESEARCH PLC GH RESEARCH PLC ORDINARY SHARES | IE000GID8VI0 | 4.31% | $1.9M | Equity (common) | Ireland | USD |
| 9 | ALKERMES PLC ALKERMES PLC SHS | IE00B56GVS15 | 4.30% | $1.9M | Equity (common) | Ireland | USD |
| 10 | ALTO NEUROSCIENCE INC ALTO NEUROSCIENCE INC COM SHS | US02157Q1094 | 4.20% | $1.9M | Equity (common) | United States | USD |
| 11 | ABBVIE INC ABBVIE INC COM | US00287Y1091 | 4.14% | $1.8M | Equity (common) | United States | USD |
| 12 | BLACKROCK TREASURY TRUST | No identifier reported | 3.97% | $1.8M | Short-term investment vehicles (cash funds) | United States | USD |
| 13 | BRIGHT MINDS BIOSCIENCES INC BRIGHT MINDS BIOSCIENCES INC COM NEW | CA10919W4056 | 3.84% | $1.7M | Equity (common) | Canada | USD |
| 14 | JOHNSON & JOHNSON JOHNSON & JOHNSON COM | US4781601046 | 3.61% | $1.6M | Equity (common) | United States | USD |
| 15 | DREY INST PREF GOV MM-M | No identifier reported | 3.10% | $1.4M | Short-term investment vehicles (cash funds) | United States | USD |
| 16 | SUPERNUS PHARMACEUTICALS INC SUPERNUS PHARMACEUTICALS INC COM | US8684591089 | 2.89% | $1.3M | Equity (common) | United States | USD |
| 17 | NEUPHORIA THERAPEUTICS INC NEUPHORIA THERAPEUTICS INC COM | US64136E1029 | 2.49% | $1.1M | Equity (common) | United States | USD |
| 18 | NEURONETICS INC NEURONETICS INC COM | US64131A1051 | 2.17% | $966K | Equity (common) | United States | USD |
| 19 | QUANTUM BIOPHARMA LTD QUANTUM BIOPHARMA LTD CL B SUB VTG SHS | CA74764Y2050 | 1.66% | $737K | Equity (common) | Canada | USD |
| 20 | OPTIMI HEALTH CORP OPTIMI HEALTH CORP COMMON SHARES | CA68405H3080 | 1.18% | $523K | Equity (common) | Canada | USD |
| 21 | PASITHEA THERAPEUTICS CORP PASITHEA THERAPEUTICS CORP COM NEW | US70261F2020 | 1.09% | $483K | Equity (common) | United States | USD |
| 22 | SILO PHARMA INC SILO PHARMA INC COM | US82711P3001 | 1.06% | $469K | Equity (common) | United States | USD |
| 23 | PSYENCE BIOMEDICAL LTD PSYENCE BIOMEDICAL LTD COM SHS | CA74449F4078 | 0.84% | $374K | Equity (common) | Canada | USD |
| 24 | INCANNEX HEALTHCARE INC INCANNEX HEALTHCARE INC COM | US45333F2083 | 0.52% | $229K | Equity (common) | United States | USD |
| 25 | NUMINUS WELLNESS INC NUMINUS WELLNESS INC COM | CA67054W1032 | 0.47% | $209K | Equity (common) | Canada | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 95.93% | |
| Short-term investment vehicles (cash funds) | 7.07% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 57.74% | |
| Canada | 25.20% | |
| United Kingdom | 11.45% | |
| Ireland | 8.61% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 103.00% | |
| Canadian dollar (CAD) | 0.00% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 15.02% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $1.6840
- 12-month yield
- 7.92%
- Frequency
- Quarterly
- Latest ex-date
- 22 Dec 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ($1.6840) ÷ latest price ($21.27) × 100 = 7.92%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (8 payments)
| Ex-date | Amount per unit |
|---|---|
| 22 Dec 2025 | $1.6840 |
| 22 Sep 2025 | $0.0200 |
| 23 Jun 2025 | $0.0120 |
| 21 Mar 2025 | $0.1630 |
| 23 Dec 2024 | $0.0550 |
| 23 Sep 2024 | $0.1090 |
| 25 Sep 2023 | $0.0300 |
| 26 Sep 2022 | $0.5400 |
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000072085) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- PSIL and VT Vanguard Total World Stock Index ETF
- PSIL and SMH VanEck Semiconductor ETF
- PSIL and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- PSIL and CGDV Capital Group Dividend Value ETF